𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Further trials of a vaccine against American cutaneous leishmaniasis

✍ Scribed by W. Mayrink; C.M.F. Antunes; C.A. Da Costa; M.N. Melo; M. Dias; M.S. Michalick; P.A. Magalhães; A. De Oliveira Lima; P. Williams

Publisher
Elsevier Science
Year
1986
Tongue
English
Weight
112 KB
Volume
80
Category
Article
ISSN
0035-9203

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a killed Le
Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial
✍ Ivan Dario Vélez; Sonia del Pilar Agudelo; Maria Patricia Arbelaez; Katherine Gi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 699 KB

The safety and immunogenicity of an intramuscular (i.m.) and intradermal (ID) formulation of autoclaved Leishmania (Leishmania) amazonensis vaccine was evaluated in 296 volunteers in a randomized, placebo-controlled, double-blind trial in Colombia. There were 4 vaccination groups: i.m. vaccine, i.m.

American Cutaneous Leishmaniasis unrespo
American Cutaneous Leishmaniasis unresponsive to antimonial drugs: successful treatment using combination of N-Methilglucamine Antimoniate plus Pentoxifylline
✍ André Báfica; Fabiano Oliveira; Luiz A. R. Freitas; Eliane G. Nascimento; Aldin 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 237 KB

## Summary **Background** American cutaneous leishmaniasis is characterized by single or multiple ulcerations. Cytokines, among other factors, have been shown to influence lesion development and tumoral necrosis factor‐alpha is a major cytokine implicated in pathogenesis of ulcers. **Observations*